CIS Oncology to showcase new ChemoCare V6 at BOPA

CIS Oncology is to exhibit at the 17th British Oncology Pharmacy Association (BOPA) Annual Symposium on 17-19 October 2014 at the ICC in Birmingham. CIS Oncology provides ChemoCare, the system of choice for chemotherapy prescribing in over 70% of NHS hospitals, helping healthcare professionals to electronically prescribe, prepare and administer chemotherapy safely and with certainty. The company will be showcasing its new, touch screen ChemoCare V6 product on stand 9.  

ChemoCare V6 has been designed to ensure clinical service flexibility and technology compliance and to enable chemotherapy services to develop in line with national requirements set out in the commissioning service framework. The team at CIS Oncology will be demonstrating the new touch screen functionality during the show.

Tony Pegg, CEO of CIS Oncology says: "We are looking forward to sharing our vision for the next generation of ChemoCare with our users and visitors throughout BOPA. Please come and visit us on stand 9, or contact us at info@cis-healthcare.com to set up a meeting during or after the conference."

Follow us on @CISoncology to keep up to speed with all our latest developments.

CIS Oncology Ltd is dedicated to helping healthcare professionals electronically prescribe, prepare and administer chemotherapy safely and with certainty  (www.cis-healthcare.com/) For further information, please contact Nick Walker, Sales Director of CIS Oncology on  07717 794340 or Suzie Creighton of Castlegate Communications on 01395 222 793  / 0772 999 3721 or  suzie@castlegatecommunications.co.uk